Drug Delivery
GelVac phase I clinical trial initiated
Published in Biotech Business Week, April 11th, 2005
The double-blind, randomized, three-way crossover study is intended to evaluate the nasal deposition of the GelVac powder as well as to assess the safety and determine the nasal retention characteristics of the GelVac system.
The GelVac system incorporates Carrington's proprietary functional pharmaceutical excipient, GelSite polymer. In animal models, it has been shown to confer two critical properties that could improve nasal immune response: mucoadhesiveness and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Finance
Maker of glucose-monitoring devices reports drop in revenues, seeks dissolution - HIV/AIDS
Enrollment initiated in phase I/II study for new HIV entry inhibitor - Heart Failure
Cardiac resynchronization therapy saves lives, reduces hospitalizations - Mergers & Acquisitions
Epimmune and immunotherapy company to combine businesses - Patents
Test to predict genetic predisposition to poor metabolism of drugs wins patent - Actinic Keratosis
Clinical trial for non-melanoma skin cancer and actinic kertosis initiated - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
